Demographic patient data and blood count of patients with active sarcoma and control groups. Demographic patient data (age, BMI) and blood count (hemoglobin level, platelet count and leukocyte count) of patients with active synovial sarcoma compared to healthy donors, patients with synovial sarcoma in remission and patients with active leiomyosarcoma, MPNST, Ewing sarcoma and liposarcoma. Data are presented as mean value ± standard error of mean (SEM). p- values were determined using a Student’s t-test for independent samples. Hb = Hemoglobin. BMI = Body Mass Index. (PPTX 68 kb
All NCCN biomarkers for sarcoma,including diagonosis and therapy determination (XLSX 17 kb
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...
Representative fluorescence-activated cell sorting (FACS) dot plots. A. Forward and side scatter of ...
Demographic patient data and blood count of patients with active sarcoma (Individual Cohort (IC)) an...
Illustration of the miRNA-expression levels of the two active synovial sarcoma patients who received...
Comparison of whole blood miRNA expression levels of patients with active synovial sarcoma and miRNA...
Disease and therapy status of sarcoma patients. M0 = localized disease. M1 = metastatic disease. Cur...
Figure S1. Levels of free hemoglobin were measured in plasma samples by spectrophotometry at wavelen...
Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets. Figure S...
miRNA profiles of the RA patients with ILD. Standard deviations are shown in parenthesis. Difference...
Table S1. Characteristics of patients with atypical myeloproliferative neoplasms (n = 18). Table S2....
Samples annotation for sarcoma patients and cell lines in the study. (XLSX 45 kb
Clinical characteristics of the Boston, Utah, and Texas datasets. These published datasets were used...
Figure S1. Optimal cluster estimation based on silhouette score. Figure S2. Principal component anal...
Differentially expressed miRNAs between the two subtypes in the three datasets. The Boston, Utah, an...
All NCCN biomarkers for sarcoma,including diagonosis and therapy determination (XLSX 17 kb
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...
Representative fluorescence-activated cell sorting (FACS) dot plots. A. Forward and side scatter of ...
Demographic patient data and blood count of patients with active sarcoma (Individual Cohort (IC)) an...
Illustration of the miRNA-expression levels of the two active synovial sarcoma patients who received...
Comparison of whole blood miRNA expression levels of patients with active synovial sarcoma and miRNA...
Disease and therapy status of sarcoma patients. M0 = localized disease. M1 = metastatic disease. Cur...
Figure S1. Levels of free hemoglobin were measured in plasma samples by spectrophotometry at wavelen...
Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets. Figure S...
miRNA profiles of the RA patients with ILD. Standard deviations are shown in parenthesis. Difference...
Table S1. Characteristics of patients with atypical myeloproliferative neoplasms (n = 18). Table S2....
Samples annotation for sarcoma patients and cell lines in the study. (XLSX 45 kb
Clinical characteristics of the Boston, Utah, and Texas datasets. These published datasets were used...
Figure S1. Optimal cluster estimation based on silhouette score. Figure S2. Principal component anal...
Differentially expressed miRNAs between the two subtypes in the three datasets. The Boston, Utah, an...
All NCCN biomarkers for sarcoma,including diagonosis and therapy determination (XLSX 17 kb
BMC Med Gen Submission - Jones 2019_Novel sarcoma risk genes in cancer cluster families_Supp Materia...
Representative fluorescence-activated cell sorting (FACS) dot plots. A. Forward and side scatter of ...